Key molecular players in both pathways have been identified: 53BP1, first identified as a DNA damage checkpoint protein, and Breast cancer type 1 susceptibility protein (BRCA1), a well-known breast cancer tumor suppressor,17 are at the center of molecular networks that coordinate NHEJ and HR, respectively. The gene discussed is BRCA1; the disease is breast carcinoma.